1232 related articles for article (PubMed ID: 32878912)
1. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
[TBL] [Abstract][Full Text] [Related]
2. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
[TBL] [Abstract][Full Text] [Related]
3. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
[TBL] [Abstract][Full Text] [Related]
4. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients.
Sun B; Feng Y; Mo X; Zheng P; Wang Q; Li P; Peng P; Liu X; Chen Z; Huang H; Zhang F; Luo W; Niu X; Hu P; Wang L; Peng H; Huang Z; Feng L; Li F; Zhang F; Li F; Zhong N; Chen L
Emerg Microbes Infect; 2020 Dec; 9(1):940-948. PubMed ID: 32357808
[TBL] [Abstract][Full Text] [Related]
6. Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study.
Wang QJ; Yao YZ; Song JS; Wang Q; Xu LY; Bao ZJ; Mao DW; Zhou JH; Zhang ZE; Wang Y; Li YW; Wang HP; Li L; Pan HY; Zhang GQ; Li SB
BMC Infect Dis; 2020 Nov; 20(1):818. PubMed ID: 33167900
[TBL] [Abstract][Full Text] [Related]
7. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
Marklund E; Leach S; Axelsson H; Nyström K; Norder H; Bemark M; Angeletti D; Lundgren A; Nilsson S; Andersson LM; Yilmaz A; Lindh M; Liljeqvist JÅ; Gisslén M
PLoS One; 2020; 15(10):e0241104. PubMed ID: 33085715
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune responses to covid-19.
Sewell HF; Agius RM; Stewart M; Kendrick D
BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
[No Abstract] [Full Text] [Related]
9. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
[TBL] [Abstract][Full Text] [Related]
10. Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2.
Konwarh R
Front Immunol; 2020; 11():1531. PubMed ID: 32655584
[No Abstract] [Full Text] [Related]
11. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.
Iyer AS; Jones FK; Nodoushani A; Kelly M; Becker M; Slater D; Mills R; Teng E; Kamruzzaman M; Garcia-Beltran WF; Astudillo M; Yang D; Miller TE; Oliver E; Fischinger S; Atyeo C; Iafrate AJ; Calderwood SB; Lauer SA; Yu J; Li Z; Feldman J; Hauser BM; Caradonna TM; Branda JA; Turbett SE; LaRocque RC; Mellon G; Barouch DH; Schmidt AG; Azman AS; Alter G; Ryan ET; Harris JB; Charles RC
Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33033172
[TBL] [Abstract][Full Text] [Related]
12. Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Rijkers G; Murk JL; Wintermans B; van Looy B; van den Berge M; Veenemans J; Stohr J; Reusken C; van der Pol P; Reimerink J
J Infect Dis; 2020 Sep; 222(8):1265-1269. PubMed ID: 32726417
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate.
Addetia A; Crawford KHD; Dingens A; Zhu H; Roychoudhury P; Huang ML; Jerome KR; Bloom JD; Greninger AL
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32826322
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A
Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
[TBL] [Abstract][Full Text] [Related]
16. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.
Guo X; Zeng L; Huang Z; He Y; Zhang Z; Zhong Z
Front Immunol; 2020; 11():1936. PubMed ID: 32849650
[No Abstract] [Full Text] [Related]
17. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia.
Roeker LE; Knorr DA; Pessin MS; Ramanathan LV; Thompson MC; Leslie LA; Zelenetz AD; Mato AR
Leukemia; 2020 Nov; 34(11):3047-3049. PubMed ID: 32855439
[No Abstract] [Full Text] [Related]
18. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.
Jiang HW; Li Y; Zhang HN; Wang W; Yang X; Qi H; Li H; Men D; Zhou J; Tao SC
Nat Commun; 2020 Jul; 11(1):3581. PubMed ID: 32665645
[TBL] [Abstract][Full Text] [Related]
19. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
20. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
Isho B; Abe KT; Zuo M; Jamal AJ; Rathod B; Wang JH; Li Z; Chao G; Rojas OL; Bang YM; Pu A; Christie-Holmes N; Gervais C; Ceccarelli D; Samavarchi-Tehrani P; Guvenc F; Budylowski P; Li A; Paterson A; Yue FY; Marin LM; Caldwell L; Wrana JL; Colwill K; Sicheri F; Mubareka S; Gray-Owen SD; Drews SJ; Siqueira WL; Barrios-Rodiles M; Ostrowski M; Rini JM; Durocher Y; McGeer AJ; Gommerman JL; Gingras AC
Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33033173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
